Vigna_2022_J.Clin.Lipidol_16_591

Reference

Title : Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations - Vigna_2022_J.Clin.Lipidol_16_591
Author(s) : Vigna GB , Citroni N , Tarugi P , Fellin R
Ref : J Clin Lipidol , 16 :591 , 2022
Abstract :

Familial chylomicronemia syndrome (FCS) is a rare and severe genetic disorder, characterized by marked elevation of plasma triglycerides, often diagnosed in infancy. We describe the long-term follow-up (almost 60 years), the diagnostic assessment and the management of two siblings with severe hypertriglyceridemia and a history of pancreatitis who also developed cardiovascular complications later in life. We recently disclosed that the surviving index case was homozygous for a pathogenic LPL gene variant (c.984 G>T, p.M328I). The same variant was also found in two apparently unrelated siblings with FCS living in the same geographical area as the index case.

PubMedSearch : Vigna_2022_J.Clin.Lipidol_16_591
PubMedID: 35945124
Gene_locus related to this paper: human-LPL

Related information

Citations formats

Vigna GB, Citroni N, Tarugi P, Fellin R (2022)
Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations
J Clin Lipidol 16 :591

Vigna GB, Citroni N, Tarugi P, Fellin R (2022)
J Clin Lipidol 16 :591